01 MINOCYCLINE HYDROCHLORIDE (5)
01 JOURNEY (5)
01 CAPSULE, EXTENDED RELEASE;ORAL (5)
01 EQ 112.5MG BASE (1)
02 EQ 135MG BASE (1)
03 EQ 45MG BASE (1)
04 EQ 67.5MG BASE (1)
05 EQ 90MG BASE (1)
01 USA (5)
19
JMC Corporation KR, based in South Korea, is a pharmaceutical company.
One of their notable products is MINOCYCLINE HYDROCHLORIDE, with a corresponding application number 201922 and regulatory information .
proudly manufactured in the
approval since 2012-07-11
JMC Corporation KR's XIMINO CAPSULE, EXTENDED RELEASE;ORAL, medication with EQ 135MG BASE of MINOCYCLINE HYDROCHLORIDE.
18
JMC Corporation KR, based in South Korea, is a pharmaceutical company.
One of their notable products is MINOCYCLINE HYDROCHLORIDE, with a corresponding application number 201922 and regulatory information .
proudly manufactured in the
approval since 2012-07-11
JMC Corporation KR's XIMINO CAPSULE, EXTENDED RELEASE;ORAL, medication with EQ 90MG BASE of MINOCYCLINE HYDROCHLORIDE.
17
JMC Corporation KR, based in South Korea, is a pharmaceutical company.
One of their notable products is MINOCYCLINE HYDROCHLORIDE, with a corresponding application number 201922 and regulatory information .
proudly manufactured in the
approval since 2012-07-11
JMC Corporation KR's XIMINO CAPSULE, EXTENDED RELEASE;ORAL, medication with EQ 45MG BASE of MINOCYCLINE HYDROCHLORIDE.
16
JMC Corporation KR, based in South Korea, is a pharmaceutical company.
One of their notable products is MINOCYCLINE HYDROCHLORIDE, with a corresponding application number 201922 and regulatory information .
proudly manufactured in the
approval since 2012-07-11
JMC Corporation KR's XIMINO CAPSULE, EXTENDED RELEASE;ORAL, medication with EQ 112.5MG BASE of MINOCYCLINE HYDROCHLORIDE.
15
JMC Corporation KR, based in South Korea, is a pharmaceutical company.
One of their notable products is MINOCYCLINE HYDROCHLORIDE, with a corresponding application number 201922 and regulatory information .
proudly manufactured in the
approval since 2012-07-11
JMC Corporation KR's XIMINO CAPSULE, EXTENDED RELEASE;ORAL, medication with EQ 67.5MG BASE of MINOCYCLINE HYDROCHLORIDE.